Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Blood|February 10, 2006
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphomaDouglas A Stewart, Nizar Bahlis, Karen Valentine, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|September 8, 2021
Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian CenterVictor H Jimenez-Zepeda, Patrick Yau, Douglas Stewart, et al.
Autophagy|January 17, 2013
Reovirus modulates autophagy during oncolysis of multiple myelomaChandini M Thirukkumaran, Zhong Qiao Shi, Joanne Luider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Reovirus as a viable therapeutic option for the treatment of multiple myelomaChandini M Thirukkumaran, Zhong Qiao Shi, Joanne Luider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.
Cancer Medicine|October 13, 2020
Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patientsAndrew Belch, Nizar Bahlis, Darrell White, et al.
Annals of Hematology|August 26, 2022
Amyloidosis and COVID-19: experience from an amyloid program in CanadaEllen Lewis, Nowell Fine, Robert J H Miller, et al.
British Journal of Haematology|August 1, 2012
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomibRavi Vij, David S Siegel, Sundar Jagannath, et al.
Science Advances|October 13, 2021
Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancerAna Nikolic, Divya Singhal, Katrina Ellestad, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myelomaSundar Jagannath, Ravi Vij, A Keith Stewart, et al.
Pageof 6